User login
This supplement highlights the efficacy and safety of using SGLT-2 inhibitors in the individualized treatment of type 2 diabetes.
Faculty/Faculty Disclosure
Eden M. Miller, DO
Executive Director and Co-founder, Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon
Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.
This supplement highlights the efficacy and safety of using SGLT-2 inhibitors in the individualized treatment of type 2 diabetes.
Faculty/Faculty Disclosure
Eden M. Miller, DO
Executive Director and Co-founder, Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon
Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.
This supplement highlights the efficacy and safety of using SGLT-2 inhibitors in the individualized treatment of type 2 diabetes.
Faculty/Faculty Disclosure
Eden M. Miller, DO
Executive Director and Co-founder, Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon
Competing Interest and Financial Disclosures: Dr. Miller discloses that she is on the advisory boards and speakers’ bureaus for AstraZeneca, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc.